TEAM IIb trial results: Adjuvant ibandronate in early breast cancer
TEAM IIb trial results: Adjuvant ibandronate in early breast cancer
Neoadjuvant abemaciclib for HR positive, HER negative breast cancer
TCHP with/out oestrogen for HR/HER positive breast cancer
Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in metastatic breast cancer
Extended adjuvant endrocine therapy with letrozole after aromatase inhibition
Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer
PrECOG: Added everolimus extends PFS for HR positive, HER2 negative breast cancer
Editor's Choice for November 2016
Managing breast cancer in low and middle income countries
Quality of life in geriatric population
New optimism for advanced breast cancer patients failing antiestrogens: Opening audience survey
Biology and function of CDKs